Selection of Artificial Heart Devices
The number of patients with advanced heart failure that has become unresponsive to conventional medical therapy is increasing rapidly. One of the most promising new alternatives to heart transplantation is use of artificial heart devices. The field of mec
- PDF / 4,360,982 Bytes
- 220 Pages / 439.42 x 683.15 pts Page_size
- 43 Downloads / 160 Views
tificial Hearts
Technology and Therapy Management
Artificial Hearts
Ming Yang Editor
Artificial Hearts Technology and Therapy Management
Editor Ming Yang Department of Instrument Science and Engineering Shanghai Jiao Tong University Shanghai, China
ISBN 978-981-15-4377-7 ISBN 978-981-15-4378-4 https://doi.org/10.1007/978-981-15-4378-4
(eBook)
© Springer Nature Singapore Pte Ltd. 2020 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors, and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, expressed or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. This Springer imprint is published by the registered company Springer Nature Singapore Pte Ltd. The registered company address is: 152 Beach Road, #21-01/04 Gateway East, Singapore 189721, Singapore
Foreword
With the aging of global population and rising prevalence of poorly controlled risk factors, cardiovascular disease has become the leading cause of death worldwide. It is reported that there are more than 26 million heart failure patients in the world. Although most of them can be treated by medication and surgery, some end-stage heart failure patients need special treatment, such as heart transplantation, ventricular assist therapy, and so on. In recent decades, heart transplantation has become the gold standard for the treatment of end-stage heart failure, but the donor is seriously insufficient, and there is an urgent need for alternative treatment. Ventricular assist devices are undoubtedly one of the most promising treatment methods. Fuwai hospital, the largest cardiac center in China, is committed to providing effective treatment for patients with heart failure who cannot benefit from conventional treatment. We have experienced the first generation of artificial heart products such as BVS 5000, AB 5000, MEDOS, Novacor, etc., to the development and clinical trials of the third generation of suspended artificial heart, such as CH VAD, etc. I have demonstrated that VAD implantation is an alternative choice for end-stage he
Data Loading...
